On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

ChineseInvestors.com, Inc. (CIIX) Markets Hemp-Infused CBD Skin Care Line in China with Multi-Platform Strategy

  • CIIX’s goal is 100% growth, cost cuts and profitability in FY2018 after recording 76% YOY operating sales jump in FY2017
  • Valuation of CIIX “could explode with this huge potential market in China of 1.4 billion people,” according to investor relations director in SmallCapVoice interview
  • Consilium Global Research projects CIIX sales will reach $14.8 million by FY2020

ChineseInvestors.com, Inc. (OTCQB: CIIX) is growing in numerous directions due to its diverse strategy of marketing, communications and product development both within China and to the global Chinese-speaking community. After recording YOY operating sales gains of 130% in investor relations and 57% in subscription revenue in FY2017, CEO Warren Wang said that the company’s goal is 100% more growth in FY2018 while cutting costs and achieving profitability. Overall, the company showed 76% YOY operating sales growth in FY2017. Diversity is the key to this skyrocketing growth (http://cnw.fm/Kl9Ud).

Through its subsidiary, CBD Biotechnology Co. Ltd., CIIX is marketing, to the 1.4 billion people of China, its CBD-infused skin care line through multiple-channels, including retail, social media and direct marketing, Alan Klitenic, director of investor relations for CIIX, told SmallCapVoice.com in an interview (http://cnw.fm/J5OHp).

CIIX has a goal of becoming the primary Chinese publicly traded company in the medical cannabis industry. Its focus is on distributing legalized cannabidiol (CBD) to the worldwide Chinese-speaking community. Consilium Global Research projects that CIIX sales will reach $14.8 million by FY2020 (http://cnw.fm/56NbO). The Hemp Business Journal estimates that the CBD market will reach $2.1 billion in consumer sales by FY2020, showing a compound annual growth rate (CAGR) of 80%, per Consilium Global Research.

Klitenic added that CIIX’s two divisions exhibited double- and triple-digit growth in FY2017. As it markets its line of hemp oil-infused skin care products, he said, the firm will target a large audience in China and the U.S. “We will also be selling through ecommerce on eBay and Amazon,” he said. “Our goal is to maximize revenues and shareholder value.”

He explained that by marketing the regulatory agency-approved CBD-infused skin care line in China, “Our valuation could explode with this huge potential market.” Klitenic said that the company is ready to make sales in China and spend dollars to be promotional and build its brand. Cannabis is known to have anti-inflammatory and antioxidant properties. The products have fatty acids in their hemp seed oil that improve skin complexion and maintain the skin’s moisture, according to company data.

Klitenic also noted that, this month, CIIX is planning to start broadcasting from the NYSE to its Chinese-speaking audience, offering information and video news about cryptocurrencies. “We are only an educational and news provider,” he said, aiming to answer the many questions it receives. “We recently acquired the domain name, newcoin168.com, to begin offering this video news service.”

For more information, visit the company’s website at www.ChineseInvestors.com

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
303.498.7722 Office


Select A Month

Contact us: 303.498.7722